Therapeutic Area | MeSH |
---|---|
musculoskeletal diseases | D009140 |
nutritional and metabolic diseases | D009750 |
Brand Name | Status | Last Update |
---|---|---|
evenity | Biologic Licensing Application | 2024-10-31 |
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
postmenopausal osteoporosis | EFO_0003854 | D015663 | — |
Code | Description |
---|---|
J3111 | Injection, romosozumab-aqqg, 1 mg |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Osteoporosis | D010024 | EFO_0003882 | M81.0 | — | — | 1 | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Bone fractures | D050723 | EFO_0003931 | T14.8 | — | 1 | — | — | — | 1 |
Fracture healing | D017102 | — | — | — | 1 | — | — | — | 1 |
Drug common name | Romosozumab |
INN | romosozumab |
Description | Romosozumab (humanized mab) |
Classification | Antibody |
Drug class | monoclonal antibodies |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | — |
PDB | — |
CAS-ID | — |
RxCUI | — |
ChEMBL ID | CHEMBL2107874 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | DB11866 |
UNII ID | 3VHF2ZD92J (ChemIDplus, GSRS) |